Delivery Order SPE2DB22D2007-SPE2DB24FJ0ST
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $5,624.62 for the supply of Tasigna 150 mg capsules. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare supplier for the U.S. Department of Defense. AmerisourceBergen, a large pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $16,873.86 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a prescription medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tasigna 150 mg capsules. The contract is a Delivery Order valued at $16,873.86, with a firm fixed price and a completion date of May 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,249.24 firm fixed price delivery order is for the supply of the prescription drug Tasigna, a 150 mg capsule product, to support government healthcare programs. The contract has a completion date of July 15, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,624.62 firm fixed-price delivery order covers the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a period of performance through December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,819.01, is a Firm Fixed Price Delivery Order for the drug Tasigna 150 mg Capsule 28s. The award has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of TASIGNA 150 MG CAPSULE 28S. The $5,624.62 firm fixed price delivery order has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, a Delivery Order valued at $16,554.27, is for the supply of Tasigna 150 mg capsules. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The single-award, indefinite delivery contract (IDC) has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,498.48 firm-fixed-price delivery order is for the supply of Tasigna 200 mg capsules. The contract has an ultimate completion date of July 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0STDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $16,873.86 firm fixed price delivery order is for the supply of Tasigna 150mg capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA for the provision of pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 3/19/24 |